It is revealed that bone marrow myeloid progenitors harbor a heritable inflammatory transcriptional state that is transmitted to their BAM progeny, driving neuroinflammation and cognitive deterioration, and conserved in human aging.
Abstract
Aging is associated with progressive neuroinflammation and cognitive decline, yet the cellular sources that sustain this process and whether they can be targeted peripherally remain unclear. Here, we identify inflammatory border-associated macrophages (BAMs) as key drivers of neuroinflammation in aging and show that their therapeutic and prophylactic elimination through intrathecal CAR T cell therapy restores cognitive performance in mouse models of aging and Alzheimer’s disease. Furthermore, targeting of aged inflammatory bone marrow myeloid progenitors through either intravenous CAR T cells, which do not infiltrate the brain, or through transplantation of CAR T-treated progenitors is sufficient to reduce neuroinflammation and cognitive impairment. These findings reveal that bone marrow myeloid progenitors harbor a heritable inflammatory transcriptional state that is transmitted to their BAM progeny, driving neuroinflammation and cognitive deterioration, and conserved in human aging. Critically, this proinflammatory state is marked by the upregulation of surface proteins, enabling precise peripheral CAR T cell targeting of these progenitors for long-lasting therapeutic effects in cognitive aging.
This framework aims to move senescence-targeted treatment beyond broad senolysis and toward testable precision strategies for aging bone by operationalizing cell- and stage-resolved therapeutic windows.
Lan Zhang, Yao Yao, Jinxv Chen· Frontiers in Immunology· 0 citations
Patients with chronic traumatic brain injury (cTBI) experience long-term exacerbated neurological decline, which is even more severe in older patients, yet the underlying mechanisms remain unclear. Cranial bone marrow (CBM) has recently been recognized as an adjacent immune surveillance organ of the brain that rapidly...
Zhi-Chao Lu, Chen-Xing Wang, Pei-Pei Gong et al.· Science Translational Medici...· 0 citations
Early-life severe infection is increasingly recognized as a cause of persistent cognitive impairment; however, the mechanisms by which peripheral immune cells drive and sustain chronic neuroinflammation remain poorly understood. Although infiltrating peripheral myeloid cells are generally considered transient populatio...
It is revealed that regulatory T cells within the bone marrow microenvironment actively safeguard the survival of aged HSCs via a previously uncharacterized signaling pathway, and targeted BIRC6 inhibition in HSCs using antibody-conjugated lipid nanoparticle-encapsulated antisense oligonucleotides (LNP-ASOs) significan...
Wei-Nian Liao, Fang-Ze Shao, Shao-Yan Wang et al.· Signal Transduction and Targ...· 0 citations
Regulatory T cells are well known for their immunomodulatory role but also their regenerative function is increasingly recognized across multiple tissue types including skeletal muscle, lung and the central nervous system (CNS). In the CNS, Tregs have been shown to promote oligodendrocyte precursor cell differentiation...
Sarah Chenine, A. Tiane, P. Baeten et al.· Frontiers in Immunology· 0 citations
Findings identify a previously unrecognised CD11c⁺ microglia–T-cell axis that establishes immune dysfunction in DMG and provide a rationale for combining myeloid- and T cell-targeted immunotherapies.
Austėja Balevičiūtė, C. Cuesta-Martí, Jessica Hincks et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.